Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | F13A1 | P00488 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.36 |
| ▸ | CA4 | P22748 | 2/20 | 0.36 |
| ▸ | CA6 | P23280 | 2/20 | 0.36 |
| ▸ | CA5A | P35218 | 2/20 | 0.36 |
| ▸ | THPO | P40225 | 2/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.36 |
| ▸ | CASP2 | P42575 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28897325 | 1.00 | LMNA (0.48) | LMNATSHRALDH1A1CYP2C19CYP1A2 | |
| SCHEMBL518519 | 1.00 | LMNA (0.48) | LMNATSHRALDH1A1CYP2C19CYP1A2 | |
| SCHEMBL516335 | 1.00 | LMNA (0.48) | LMNATSHRALDH1A1CYP2C19CYP1A2 | |
| SCHEMBL240286 | 1.00 | LMNA (0.48) | LMNATSHRALDH1A1CYP2C19CYP1A2 | |
| SCHEMBL1507434 | 1.00 | LMNA (0.48) | LMNATSHRALDH1A1CYP2C19CYP1A2 | |
| SCHEMBL1507386 | 1.00 | LMNA (0.48) | LMNATSHRALDH1A1CYP2C19CYP1A2 | |
| SCHEMBL24346553 | 1.00 | LMNA (0.48) | LMNATSHRALDH1A1CYP2C19CYP1A2 | |
| SCHEMBL1507574 | 1.00 | LMNA (0.48) | LMNATSHRALDH1A1CYP2C19CYP1A2 | |
| SCHEMBL1507533 | 1.00 | LMNA (0.48) | LMNATSHRALDH1A1CYP2C19CYP1A2 | |
| SCHEMBL1507527 | 1.00 | LMNA (0.48) | LMNATSHRALDH1A1CYP2C19CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119956131-A | Rhenium extractant composition, rhenium extractant and method for extracting rhenium | 中国恩菲工程技术有限公司 | 2025-05-09 | — | — | CN | claimed |
| US-9226925-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2016-01-05 | — | — | US | claimed |
| US-8940729-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2015-01-27 | — | — | US | claimed |
| US-8912217-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2014-12-16 | — | — | US | claimed |
| CN-119956131-A | Rhenium extractant composition, rhenium extractant and method for extracting rhenium | 中国恩菲工程技术有限公司 | 2025-05-09 | — | — | CN | disclosed |
| EP-3647396-A1 | LUBRICANT, METAL MATERIAL, METHOD FOR PLASTICALLY FORMING METAL MATERIAL, AND METHOD FOR PRODUCING FORMED METAL MATERIAL | Nihon Parkerizing Co., Ltd. (JP) | 2020-05-06 | — | — | EP | disclosed |
| CN-110662823-A | Lubricant, metal material, method for plastic working of metal material, and method for producing formed metal material | 日本帕卡濑精株式会社 | 2020-01-07 | — | — | CN | disclosed |
| US-20190248958-A1 | PREPARATION METHOD OF OLIGOMER ADDITIVE, OLIGOMER ADDITIVE, AND LITHIUM BATTERY | NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (TW) | 2019-08-15 | — | — | US | disclosed |
| US-9226925-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2016-01-05 | — | — | US | disclosed |
| US-8980880-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2015-03-17 | — | — | US | disclosed |
| US-8957067-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2015-02-17 | — | — | US | disclosed |
| US-8940729-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2015-01-27 | — | — | US | disclosed |
| EP-0741122-A1 | Process for preparing aromatic compounds through decarboxylation of aromatic carboxylic acids | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-11-06 | — | — | EP | disclosed |
| US-5434027-A | Charge generation layer | KONICA CORPORATION (JP) | 1995-07-18 | — | — | US | disclosed |
| US-5403691-A | Forming dispersion solution of carrier generating fluorenone disazo pigment and polyvinyl butyral binder in ketone, ester or alcohol solvent having branched alkyl group, coating on conductive support | KONICA CORPORATION (JP) | 1995-04-04 | — | — | US | disclosed |
| EP-0322586-B1 | Photo-receptor for electrophotography | KONISHIROKU PHOTO IND (JP) | 1994-11-02 | — | — | EP | disclosed |
| US-5320921-A | With carrier generating layer containing polycyclic quinone and perylene compound; high sensitivity, durability and image quality | KONICA CORPORATION (JP) | 1994-06-14 | — | — | US | disclosed |
| US-5134050-A | Photoreceptor comprising the combined use of a quinone and azo compound as charge generating materials | KONICA CORPORATION (JP) | 1992-07-28 | — | — | US | disclosed |
| US-4939058-A | Durability | KONICA CORPORATION (JP) | 1990-07-03 | — | — | US | disclosed |
| EP-0322586-A2 | Photo-receptor for electrophotography | KONICA CORPORATION (JP) | 1989-07-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190248958-A1 | PREPARATION METHOD OF OLIGOMER ADDITIVE, OLIGOMER ADDITIVE, AND LITHIUM BATTERY | PCNA, SCO2, PARG | LMNA 16/4885TSHR 4451/4885ALDH1A1 3550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.